Stephan Beisken - Concepedia

Author

Stephan Beisken

Johns Hopkins University ORCID

Also Known As

Beisken, Stephan, Stephan Beisken

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine European Bioinformatics Institute Wellcome Trust Syngenta (United Kingdom)

About

Stephan Beisken is an author at Johns Hopkins University specializing in medicine, diagnostic microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	137
2	Engineering	2	2	83
3	Health Sciences	1	1	33
4	Natural Sciences	1	1	21
5	Biochemistry	1	1	21

Stephan Beisken

Publications

930

Citations

H-Index

Page 1

	Year	Citations
KNIME-CDK: Workflow-driven cheminformatics Stephan Beisken, Thorsten Meinl, Bernd Wiswedel, BMC Bioinformatics	2013	157
Progressive Development of Cefiderocol Resistance in <i>Escherichia coli</i> During Therapy is Associated With an Increase in <i>bla</i>NDM-5 Copy Number and Gene Expression Patricia J. Simner, Heba H. Mostafa, Yehudit Bergman, Clinical Infectious Diseases	2021	96
Cefiderocol Activity Against Clinical<i>Pseudomonas aeruginosa</i>Isolates Exhibiting Ceftolozane-Tazobactam Resistance Patricia J. Simner, Stephan Beisken, Yehudit Bergman, Open Forum Infectious Diseases	2021	75
Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid Matthias Klein, Johannes Bacher, Sandra Barth, Journal of Clinical Microbiology	2020	67
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance Pranita D. Tamma, Stephan Beisken, Yehudit Bergman, Clinical Infectious Diseases	2020	65
Species Identification and Antibiotic Resistance Prediction by Analysis of Whole-Genome Sequence Data by Use of ARESdb: an Analysis of Isolates from the Unyvero Lower Respiratory Tract Infection Trial Inês M. Ferreira, Stephan Beisken, Lukas Lueftinger, Journal of Clinical Microbiology EngineeringPathologyAntibiotic ResistanceHigh Throughput SequencingDrug Resistance	2020	61
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance Patricia J. Simner, Yehudit Bergman, Rick Conzemius, Open Forum Infectious Diseases	2023	58
Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales Patricia J. Simner, Stephan Beisken, Yehudit Bergman, Microbial Drug Resistance	2021	52
BiNChE: A web tool and library for chemical enrichment analysis based on the ChEBI ontology Pablo Moreno, Stephan Beisken, Bhavana Harsha, BMC Bioinformatics	2015	39
Combination of phage therapy and cefiderocol to successfully treat <i>Pseudomonas aeruginosa</i> cranial osteomyelitis Patricia J. Simner, Jerald Cherian, Gina A. Suh, JAC-Antimicrobial Resistance	2022	37

Page 1